Revenue
Cost
Profit
| Item | Category | Value | YoY |
|---|---|---|---|
| Net sales | revenue | 3.91B | 4.49% |
| Gross profit | profit | 2.30B | 6.18% |
| Cost of sales | cost | 1.61B | 2.16% |
| Operating income | profit | 767.00M | 37.46% |
| Selling, general, and administrative expenses | cost | 1.45B | -5.47% |
| Restructuring expenses | cost | 71.00M | 18.33% |
| Other operating income (expense), net | revenue | 11.00M | -15.38% |
| Income before taxes | profit | 672.00M | 46.72% |
| Interest income (expense), nonoperating | revenue | 95.00M | 1.06% |
| Net income | profit | 474.00M | 47.20% |
| Provision for taxes | cost | 198.00M | 45.59% |
| Segment | Value | YoY |
|---|---|---|
| Self Care | 1.70B | 1.92% |
| Essential Health | 1.15B | 4.92% |
| Skin Health and Beauty | 1.06B | 8.39% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Accounts receivable, after allowance for credit loss, current | assets | 2.50B | |
| Total inventories | assets | 1.67B | |
| Cash and cash equivalent | assets | 1.07B | |
| Prepaid expense and other assets, current | assets | 410.00M | |
| Other current assets | assets | 135.00M | |
| Total current assets | assets | 5.79B | |
| Goodwill | assets | 9.38B | |
| Net carrying amount | assets | 8.54B | |
| Property, plant, and equipment, net | assets | 2.21B | |
| Other assets, noncurrent | assets | 703.00M | |
| Deferred taxes on income | assets | 232.00M | |
| Due from j&j | assets | 26.85B | |
| Due to j&j | liabilities | 16.25B | |
| Total stockholders’ equity | equity | 10.61B | |
| Accumulated other comprehensive income (loss), net of tax | equity | 5.21B | |
| Treasury stock, common, value | equity | 439.00M | |
| Accumulated deficit | equity | 128.00M | |
| Total long-term debt | liabilities | 7.07B | |
| Liabilities, current, total | liabilities | 5.90B | |
| Deferred taxes on income | liabilities | 2.35B | |
| Total other liabilities | liabilities | 579.00M | |
| Employee-related liabilities | liabilities | 345.00M | |
| Aggregate | equity | 16.38B | |
| Accounts payable, current | liabilities | 2.53B | |
| Loans and notes payable | liabilities | 1.59B | |
| Total accrued liabilities | liabilities | 901.00M | |
| Accrued rebates returns and promotions, current | liabilities | 777.00M | |
| Accrued income taxes, current | liabilities | 96.00M | |
| Additional paid-in capital | equity | 16.36B | |
| Common stock, $0.01 par value, 12,500,000 shares authorized; 1,940,322 and 1,919,935 shares issued and outstanding as of march 29, 2026, respectively; 1,936,502 and 1,916,115 shares issued and outstanding as of december 28, 2025, respectively | equity | 19.00M |
| Item | Value |
|---|---|
| Net income | 474.00M |
| Depreciation, depletion and amortization | 143.00M |
| Accrued taxes on income | 33.00M |
| Share-based payment arrangement, noncash expense | 29.00M |
| Deferred income tax expense (benefit) | 28.00M |
| Other noncash income (expense) | 18.00M |
| Other liabilities | 7.00M |
| Employee-related obligations | 5.00M |
| Increase (decrease) in other operating assets | -16.00M |
| Increase (decrease) in inventories | -19.00M |
| Increase (decrease) in accounts payable and accrued liabilities | -77.00M |
| Increase (decrease) in accounts receivable | -136.00M |
| Item | Value |
|---|---|
| Payment for (proceeds from) other investing activity | -28.00M |
| Payments to acquire property, plant, and equipment | -139.00M |
| Item | Value |
|---|---|
| Proceeds from commercial paper program, net of repayments and issuance costs | 870.00M |
| Other financing activities | -17.00M |
| Payments of dividends | -398.00M |
| Repayments of senior debt | -750.00M |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 1.06B |
| Cash and cash equivalents, end of period | 1.07B |
Instantly decode complex 10-K and 10-Q data. Explore interactive Sankey diagrams for income and balance sheets, and intuitive waterfall charts for cash flows.
Search for a company and select a report on the left panel.
Request Stock Support